Poole EL - Search Results

1

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

Krishna BA, Spiess K, Poole EL, Lau B, Voigt S, Kledal TN, Rosenkilde MM, Sinclair JH. Krishna BA, et al. Among authors: poole el. Nat Commun. 2017 Feb 2;8:14321. doi: 10.1038/ncomms14321. Nat Commun. 2017. PMID: 28148951 Free PMC article.

2

The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism.

Poole E, King CA, Sinclair JH, Alcami A. Poole E, et al. EMBO J. 2006 Sep 20;25(18):4390-9. doi: 10.1038/sj.emboj.7601287. Epub 2006 Aug 24. EMBO J. 2006. PMID: 16932746 Free PMC article.

3

NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.

Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, Alcami A, Sinclair J. Poole E, et al. J Virol. 2008 May;82(9):4250-6. doi: 10.1128/JVI.02156-07. Epub 2008 Feb 20. J Virol. 2008. PMID: 18287226 Free PMC article.

4

Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J. Poole E, et al. J Virol. 2009 Apr;83(8):3581-90. doi: 10.1128/JVI.02072-08. Epub 2009 Jan 28. J Virol. 2009. PMID: 19176615 Free PMC article.

5

Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34⁺ progenitors.

Poole E, McGregor Dallas SR, Colston J, Joseph RSV, Sinclair J. Poole E, et al. J Gen Virol. 2011 Jul;92(Pt 7):1539-1549. doi: 10.1099/vir.0.031377-0. Epub 2011 Apr 6. J Gen Virol. 2011. PMID: 21471310

6

A novel neuroprotective therapy for Parkinson's disease using a viral noncoding RNA that protects mitochondrial complex I activity.

Kuan WL, Poole E, Fletcher M, Karniely S, Tyers P, Wills M, Barker RA, Sinclair JH. Kuan WL, et al. J Exp Med. 2012 Jan 16;209(1):1-10. doi: 10.1084/jem.20111126. Epub 2011 Dec 19. J Exp Med. 2012. PMID: 22184634 Free PMC article.

7

Depletion of cellular pre-replication complex factors results in increased human cytomegalovirus DNA replication.

Braun TE, Poole E, Sinclair J. Braun TE, et al. PLoS One. 2012;7(5):e36057. doi: 10.1371/journal.pone.0036057. Epub 2012 May 7. PLoS One. 2012. PMID: 22586460 Free PMC article.

8

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.

Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH. Mason GM, et al. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14538-43. doi: 10.1073/pnas.1204836109. Epub 2012 Jul 23. Proc Natl Acad Sci U S A. 2012. PMID: 22826250 Free PMC article.

9

The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus.

Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J. Poole E, et al. PLoS One. 2012;7(10):e45686. doi: 10.1371/journal.pone.0045686. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094019 Free PMC article.

10

The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J. Poole E, et al. J Virol. 2013 Apr;87(8):4261-71. doi: 10.1128/JVI.03497-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters